en · de · es · fr · pt
sermorelin-notes.peptides9002.com › Faq › Melanocortin Receptor Pharmacology — Explained

Melanocortin Receptor Pharmacology — Explained

By Editorial Desk · published 2026-02-06 · last reviewed 2026-03-20 · Faq

This is a working overview of bremelanotide, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-03-20 and is reviewed periodically as new material appears.

Melanocortin Receptor Pharmacology

The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.

Bremelanotide acts as an agonist at several melanocortin receptors, with the strongest reported activity at MC4R and measurable activity at MC1R and MC3R. Because MC4R is expressed in hypothalamic and limbic circuits, the proposed mechanism links receptor activation to modulation of central pathways involved in desire rather than to direct effects on peripheral genital tissue. The precise downstream steps remain incompletely characterized, and evidence for the involvement of specific neurotransmitters is suggestive rather than settled. Nausea and blood pressure elevation reported during trials are consistent with melanocortin signaling outside the intended target circuit.

Bremelanotide Background And Development

Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.

Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.

Pt-141 at a glance

PropertyValueNotes
Primary receptor targetMC4RHighest reported agonist potency within the family
Secondary receptor activityMC1R and MC3RLower potency than at MC4R
Elimination half-lifeAbout 2 to 3 hoursMeasured after subcutaneous administration
Plasma protein bindingApproximately 44 percentSpecies- and assay-dependent
Route of administrationSubcutaneous injectionReviewed product uses a single-use device

Background and Receptor Pharmacology

Bremelanotide acts as a non-selective agonist at melanocortin receptors, with reported activity at MC1R, MC3R, MC4R and MC5R. The proposed basis for its central effects is activation of MC4R populations in the hypothalamus, a region associated with appetite and reproductive signalling. Because the peptide carries a net positive charge and polar side chains, it does not cross biological membranes freely, which is one reason oral administration is not the standard route. Effects generally appear within an hour of parenteral administration and are described as centrally mediated rather than peripheral.

Bremelanotide, developed under the code PT-141, is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone. Its structure is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, with a lactam bridge joining the aspartate and lysine side chains. The molecule has the formula C50H68N14O10 and a monoisotopic mass near 1025 daltons. It is commonly prepared as the acetate salt and appears as a white to off-white lyophilised powder in solid form. The free acid is the pharmacologically relevant species, while the counter-ion improves handling and dissolution.

Early research on PT-141 grew out of work on melanotan II, a related cyclic peptide studied for pigmentation. Investigators observed that centrally acting melanocortin agonists also influenced sexual behaviour in animal models, and the programme shifted toward that endpoint. A nasal formulation was evaluated in clinical trials but showed inconsistent absorption, and later studies used subcutaneous administration instead. Regulatory approval in the United States followed in 2019 for a defined population of premenopausal women with acquired, generalised hypoactive sexual desire disorder. That approval was specific to that group rather than a broad indication.

Related pages on this site

Further detail

=== 7 April === The RSF launched a drone attack on Dongola Airport, destroying a fuel storage facility. Three people were killed by RSF shelling on Abu Shouk IDP camp. Several others were killed in an joint RSF and SPLM-N (al-Hilu) attack in Rashad, South Kordofan.

Hyperpigmentation, also known as dark spots, is the darkening of an area of skin or nails caused by increased melanin. Many topical treatments disrupt the synthesis of melanin by inhibiting the enzyme tyrosine hydroxylase.

== Personal life and death == Luis Moroder grew up in the small ethnic community of Ladins in the Dolomites of South Tyrol in Northern Italy. As a boy he became fascinated by natural science while accompanying his father Heinrich on mineralogical, paleontological and archaeological excursions in the mountain world of his homeland with discoveries of various fossiles that are exemplary shown in the Museum Gherdeina. Moroder was married to Anne Marie Hellrigl-Moroder with one daughter. He died on 18 May 2024, at the age of 83.

In 1958 Pius XII approved of the image in association with the devotion to the Holy Face of Jesus, and decreed that the "Feast of the Holy Winding Sheet of Christ" be celebrated every year on Shrove Tuesday. In 1936 Pius XII had referred to the Shroud as a "holy thing perhaps like nothing else". In 1998 Pope John Paul II called the Shroud a "distinguished relic" and "a mirror of the Gospel". His successor, Pope Benedict XVI, called it an "icon written with the blood of a whipped man, crowned with thorns, crucified and pierced on his right side". In 2013 Pope Francis referred to it as an "icon of a man scourged and crucified". In 1983, archbishops of the Catholic Church and Greek Orthodox Church, as well as clergy of several Protestant churches attended a prayer service at the Shroud exhibit in Turin, where they "offered their corporate blessing" to the exhibit. In 1983 the Shroud was given to the Holy See by the House of Savoy. However, as with all relics of this kind, the Roman Catholic Church made no pronouncements on its authenticity. As with other approved Catholic devotions, the matter has been left to the personal decision of the faithful, as long as the Church does not issue a future notification to the contrary. In the Church's view, whether the cloth is authentic or not has no bearing whatsoever on the validity of what Jesus taught or on the saving power of his death and resurrection. Pope John Paul II stated in 1998 that: "Since it is not a matter of faith, the Church has no specific competence to pronounce on these questions.

Sources: en.wikipedia.org

Supporting material

=== Fragment based (group contribution) === Analogously, the "partition coefficient"—a measurement of differential solubility and itself a component of QSAR predictions—can be predicted either by atomic methods (known as "XLogP" or "ALogP") or by chemical fragment methods (known as "CLogP" and other variations). It has been shown that the logP of compound can be determined by the sum of its fragments; fragment-based methods are generally accepted as better predictors than atomic-based methods. Fragmentary values have been determined statistically, based on empirical data for known logP values. This method gives mixed results and is generally not trusted to have accuracy of more than ±0.1 units. Group or fragment-based QSAR is also known as GQSAR. GQSAR allows flexibility to study various molecular fragments of interest in relation to the variation in biological response. The molecular fragments could be substituents at various substitution sites in congeneric set of molecules or could be on the basis of pre-defined chemical rules in case of non-congeneric sets. GQSAR also considers cross-terms fragment descriptors, which could be helpful in identification of key fragment interactions in determining variation of activity. Lead discovery using fragnomics is an emerging paradigm. In this context FB-QSAR proves to be a promising strategy for fragment library design and in fragment-to-lead identification endeavours. An advanced approach on fragment or group-based QSAR based on the concept of pharmacophore-similarity is developed.

The following is a timeline of the Sudanese civil war (2023–present) in 2025. This timeline is a dynamic and fluid list, and as such may never satisfy criteria of completeness. Moreover, some events may only be fully understood and/or discovered in retrospect.

=== Workforce === CMS employs over 6,000 people, of whom about 4,000 are located at its headquarters in Woodlawn, Maryland. The remaining employees are located in the Hubert H. Humphrey Building in Washington, D.C., the 10 regional offices listed below, and in various field offices located throughout the United States. The head of CMS is the administrator of the Centers for Medicare & Medicaid Services. The position is appointed by the president and confirmed by the Senate. On May 27, 2021, Chiquita Brooks-LaSure was sworn in as administrator, the first black woman to serve in the role.

=== Other RiPPs === Autoinducing Peptides (AIPs) and quorum sensing peptides are used as signaling molecules in the process called quorum sensing. AIPs are characterized by the presence of a cyclic ester or thioester, unlike other regulatory peptides that are linear. In pathogens, exported AIPs bind to extracellular receptors that trigger the production of virulence factors. In Staphylococcus aureus, AIPs are biosynthesized from a precursor peptide composed of a C-terminal leader region, the core region, and negatively charged tail region that is, along with the leader peptide, cleaved before AIP export. Bacterial Head-to-Tail Cyclized Peptides refers exclusively to ribosomally synthesized peptides with 35-70 residues and a peptide bond between the N- and C-termini, sometimes referred to as bacteriocins, although this term is used more broadly. The distinctive nature of this class is not only the relatively large size of the natural products but also the modifying enzymes responsible for macrocyclization. Other N-to-C cyclized RiPPs, such as the cyanobactins and orbitides, have specialized biosynthetic machinery for macrocylization of much smaller core peptides. Thus far, these bacteriocins have been identified only in Gram-positive bacteria. Enterocin AS-48 was isolated from Enterococcus and, like other bacteriocins, is relatively resistant to high temperature, pH changes, and many proteases as a result of macrocyclization.

== Further reading == Ahmad, Diana L. The Opium Debate and Chinese Exclusion Laws in the Nineteenth-century American West (University of Nevada Press, 2007). Drugs and Racism in the Old West. Armero and Rapaport. The Arts of an Addiction. Qing Dynasty Opium Pipes and Accessories (privately printed, 2005) Auerbach, Sascha. Race, Law and 'The Chinese Puzzle' in Imperial Britain. New York: Palgrave-Macmillan Press, 2009. Booth, Martin. Opium: A History. London: Simon & Schuster, Ltd., 1996. Chandra, Siddharth (2008). "Economic Histories of the Opium Trade". Archived from the original on September 28, 2013. Retrieved November 9, 2008. Chouvy, P.A. (2009). "Opium. Uncovering the Politics of the Poppy, London, I.B. Tauris (Cambridge, Harvard University Press: 2010)". Archived from the original on October 26, 2011. Retrieved October 20, 2009. Day, Horace B. (1868). The Opium Habit. de Quincey, Thomas (1821). Confessions of an English opium-eater. Standard Ebooks. Derks, Hans: History of the Opium Problem: The Assault on the East, ca. 1600–1950. Sinica Leidensia, 105. Leiden: Brill, 2012. ISSN 0169-9563. ISBN 978-90-04-22158-1 Dikötter, Frank, Lars Laamann, and Zhou Xun. Narcotic culture: a history of drugs in China Chicago: University of Chicago Press, 2004. Dormandy, Thomas (2012) Opium: Reality's Dark Dream, Yale University Press Fairbank, J.K. (1978) The Cambridge History of China: volume 10 part I, Cambridge, CUP Franck Daninos, L'opium légal produit en France, La Recherche, May 2005 Great Britain (1913).

Sources: en.wikipedia.org

Notes from published material

The wildlife of Brazil comprises all naturally occurring animals, plants, and fungi in the South American country. Home to 60% of the Amazon rainforest, which accounts for approximately one-tenth of all species in the world, Brazil is considered to have the greatest biodiversity of any country on the planet, containing over 70% of all animal and plant species catalogued. Brazil has the most known species of plants (55,000), freshwater fish (3,000) and mammals (over 689). It also ranks third on the list of countries with the most bird species (1,832) and second with the most reptile species (744). The number of fungal species is unknown but is large. Brazil is second only to Indonesia as the country with the most endemic species. Brazil's large territory comprises different ecosystems, such as the Amazon rainforest, recognized as having the greatest biological diversity in the world, with the Atlantic Forest and the Cerrado sustaining the greatest biodiversity. In the south, the Araucaria moist forests grow under temperate conditions. The rich wildlife of Brazil reflects the variety of natural habitats. Scientists estimate that the total number of plant and animal species in Brazil could approach four million, mostly invertebrates. Larger mammals include carnivores pumas, jaguars, ocelots, rare bush dogs, and South American foxes, and herbivores peccaries, tapirs, anteaters, sloths, opossums and armadillos. Deer are plentiful in the south, and many species of New World monkeys are found in the northern rainforests.

Official website "Prince George's County Public Schools, Maryland". Ballotpedia. "Prince George's County Public Schools District – Districts – Maryland – Best High Schools" (online). U.S. News & World Report. Washington, D.C.: U.S. News & World Report, L.P. LCCN n80001295. OCLC 809250707. Prince George's County Public Schools District contains 27 high schools. Prince George's County Public Schools at the Wayback Machine (archive index)

=== Harvey's controversy === Due to a trademark dispute with Canada's Harvey's burger chain, the Hardee's brand name cannot be used in the country. Instead, CKE Restaurants operates exclusively under the Carl's Jr. banner.

== External links == [1] Apoptosis, Trail & Caspase 8 - The Proteolysis Map-animation PDB: 1D2Q​ TRAIL+Protein at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the structural information available in the PDB for UniProt: P50591 (Tumor necrosis factor ligand superfamily member 10) at the PDBe-KB.

R-NH2 + DBNPA → R-NH-C(Br)(NO2)NH2 In basic environments, DBNPA undergoes nucleophilic substitution by hydroxide ions, which initiates hydrolysis. This reaction reduces the environmental persistence of DBNPA by breaking it down into smaller degradation products.

Sources: en.wikipedia.org

Frequently asked questions

Which receptors does bremelanotide activate?

Reported activity is highest at MC4R, with lower potency at MC1R and MC3R. The MC4R interaction is generally treated as the most relevant to its central effects. Selectivity is not absolute, and activity across the family is dose-dependent.

Does the compound reach the brain?

Indirect evidence from animal studies supports central access, and the proposed mechanism requires it. Direct quantification in humans is limited. How much reaches specific brain regions remains an open question.

What is known about its half-life?

Published descriptions give a plasma half-life of roughly two to three hours after subcutaneous administration. Values vary with assay method and study population. The figure is an average rather than a fixed molecular property.

What is bremelanotide?

It is a synthetic cyclic peptide that activates melanocortin receptors. It is given by injection and was approved in the United States in 2019 for a specific low-desire diagnosis in premenopausal women. It is not a hormonal therapy.

Network